|Day's Range||3.53 - 3.72|
|52 Week Range||3.11 - 9.50|
|PE Ratio (TTM)||-4.23|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Pacific Biosciences of California, Inc. (PACB) recently announced that it has priced its underwritten public offering of 15.4 million shares of its common stock.
Pacific Biosciences of California, AveXis and Novavax were among the biotech stock movers in premarket trading on Thursday.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pacific Biosciences of California, Inc. Here are 5 ETFs with the largest exposure to PACB-US. Comparing the performance and risk of Pacific Biosciences of California, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)